CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q2 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,769,739 | -22.7% | 254,148 | 0.0% | 0.24% | -15.4% |
| Q1 2024 | $17,818,316 | -61.6% | 254,148 | -54.3% | 0.28% | -63.2% |
| Q4 2023 | $46,420,440 | +183.4% | 556,000 | 0.0% | 0.76% | +157.8% |
| Q3 2023 | $16,379,760 | -9.7% | 556,000 | 0.0% | 0.29% | -4.2% |
| Q2 2023 | $18,136,720 | -7.3% | 556,000 | 0.0% | 0.31% | -14.5% |
| Q1 2023 | $19,565,640 | -23.2% | 556,000 | 0.0% | 0.36% | -28.5% |
| Q4 2022 | $25,475,920 | – | 556,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,700,000 | $82,365,000 | 10.13% |
| COMMODORE CAPITAL LP | 893,646 | $43,297,000 | 6.96% |
| Finepoint Capital LP | 380,793 | $18,449,000 | 6.07% |
| Boxer Capital, LLC | 2,100,000 | $101,745,000 | 5.72% |
| Opaleye Management Inc. | 263,000 | $12,742,000 | 5.26% |
| PFM Health Sciences, LP | 2,465,016 | $119,430,000 | 4.32% |
| Integral Health Asset Management, LLC | 350,000 | $16,958,000 | 3.29% |
| RTW INVESTMENTS, LP | 2,574,198 | $124,720,000 | 2.88% |
| CM Management, LLC | 50,000 | $2,423,000 | 2.70% |
| HealthCor Management, L.P. | 434,560 | $21,054,000 | 2.63% |